Senvest Management
Overview
Senvest Management, LLC is a registered investment advisor founded in 1997 by Richard Mashaal. Based in New York, the firm employs a contrarian, value-based investment strategy and serves as the investment adviser for several private pooled investment vehicles (hedge funds). It is the investment management arm of Senvest Capital Inc., which is publicly traded on the Toronto Stock Exchange.
Portfolio Companies
6
Website
senvest.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biolinq | Apr 2024 | VC Round | Co-investor |
| WATT Fuel Cell | Feb 2022 | VC Round | Co-investor |
| Tasso | Dec 2021 | Series B | Co-investor |
| Jupiter Endovascular | Oct 2025 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Senvest Management based?
Senvest Management is headquartered in New York City, New York, United States.
When was Senvest Management founded?
Founding year information for Senvest Management is not publicly available.
How many portfolio companies does Senvest Management have?
Senvest Management has 6 portfolio companies in Caplight's dataset.
What are some companies in Senvest Management's portfolio?
Portfolio companies visible on Caplight include Biolinq, WATT Fuel Cell, Tasso, Jupiter Endovascular.
What was Senvest Management's most recent investment shown here?
Senvest Management's most recent investment in this portfolio sample was in Jupiter Endovascular in 2025.
What sectors does Senvest Management focus on?
Senvest Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Senvest Management focus on?
Senvest Management typically invests at the Mid stage.
What is Senvest Management's AUM?
Senvest Management's assets under management are estimated between $3.0B and $4.4B.